SANOFICompany logo

France (FR)

OpenCorporation rating: 56.25 on 100

Ranking 2020: 136 on 569 companies


Primary NACE classification:
Manufacture of pharmaceutical preparations (2120)

Company description

The company, formerly known as Sanofi-Aventis, is engaged in the research, development, manufacturing and marketing of pharmaceutical products. It was formed in 2004 when Sanofi-Synthélabo merged with Aventis. The registered business office of the company is located in Paris, France.The company offers Lantus and Apidra analogs of human insulin; Insuman human insulin solutions and suspensions; Amaryl, a sulfonylurea; BGStar, iBGStar, and MyStar Extra blood glucose meters; enzyme replacement therapies, such as Cerezyme for Gaucher disease, Fabrazyme for Fabry, and Myozyme/Lumizyme for Pompe disease; Aldurazyme, for mucopolysaccharidosis Type I; Aubagio, a immunomodulator for multiple sclerosis; Taxotere, a taxane derivative for cancers; Eloxatine for colorectal cancer; and Jevtana for prostate cancer. It also provides thrombosis medicines, such as Plavix anti-platelet agent for atherothrombotic conditions and Lovenox to prevent and treat deep vein thrombosis; and cardiovascular medicines, including Multaq anti-arrhythmic agent and Aprovel/CoAprovel for hypertension treatments. In addition, the company provides pharmaceuticals and vaccines used by veterinarians, farmers, and pet owners; consumer health care products; and generic medicines.The company is considered one of the largest pharmaceutical companies in the world.It is a global company with operating subsidiaries in France, the United States, Singapore, Peru, Colombia, Poland, Brazil, Mexico, the Netherlands, China, Algeria, Belgium, Panama, Thailand, Hong Kong, the Czech Republic, Argentina, Sweden, Hungary, Ireland, the Republic of Korea, Indonesia, Japan, Venezuela, Canada, New Zealand, and Russian Federation.The company has strategic alliances with Bristol-Myers Squibb, Regeneron, Warner Chilcott, Regulus Therapeutics Inc., Medtronic Inc., and UCB S.A.

[…] show more

OpenCorporation questionnaire

The read only version of the questionnaire submitted to this company is publicly available: view questionnaire.

Indicators

The rating is calculated on the following metrics (for more information visit the section Methodology).

score (max is 100)
ratings 2019
53.3
53.3
93
93
57.4
65.1
43
54.8
51.2
51.2
9.7
9.7
48
60.5
20
47.5
50.4

HQ and subsidiaries

SANOFI
loading subsidiaries

* The position of map pins may not reflect the exact location

Latest news about sanofi

9 March 2020 - 12:00

35 vaccini candidati contro la Covid-19

Ci sarebbero 35 i vaccini candidati contro la Covid-19 in tutto il mondo. Qualche settimana fa erano dieci in meno. Tuttavia molti studi sono ancora in fase preclinica e i dettagli sono ancora poco chiari. La corsa all’oro del 2020, comunque, è contrassegnata anche a colpi mediatici piuttosto rilevanti dato che sempre più aziende annunciano lavori sul vaccino contro il nuovo coronavirus o, come nel caso dell’azienda americana Moderna (una delle prima ad essersi messa al lavoro) di essere vicino alla soluzione.

9 March 2020 - 12:00

Vaccino per il coronavirus. Da Moderna (Usa) all’israeliana Migal, le aziende e i laboratori al lavoro

Dalla ricerca, ha spiegato ancora l’Istituto israeliano, è stato scoperto che «il coronavirus del pollame ha un’elevata somiglianza genetica con il Covid-19 umano e che utilizza lo stesso meccanismo di infezione, un fatto che aumenta la probabilità di ottenere un vaccino umano efficace in un periodo di tempo più breve». Ma, ahinoi, mancano ancora molte «settimane» per «completare i protocolli di sicurezza che permetteranno di effettuare poi il test in vivo».

Intanto, lunedì, Donald Trump ha tenuto una riunione alla Casa Bianca per discutere la risposta della sua Amministrazione al Covid-19. Seduti attorno a un tavolo ovale, come ha raccontato nel dettaglio il New Yorker, c’erano gli esperti sanitari dei Centri per il controllo e la prevenzione delle malattie, della Food and Drug Administration e dei National Institutes of Health, oltre a dirigenti farmaceutici di Pfizer, Johnson & Johnson, Sanofi. Trump col suo modo di fare ha chiesto perentorio un vaccino entro pochi mesi. Ma la risposta di Anthony Fauci, direttore del National Institute of Allergy and Infectious Diseases, è stata una doccia fredda: «Un vaccino creato e testato in un anno non è un vaccino che si può usare». Fauci ha spiegato che l’orizzonte di attesa - prima di avere un vaccino - non può essere inferiore a un anno, un anno e mezzo. Insomma, prima del 2021 non se ne parla.

9 March 2020 - 12:00

These nine companies are working on coronavirus treatments or vaccines — here’s where things stand

The list includes Gilead Sciences Inc. and Moderna Inc. along with smaller biotechs

In the U.S., the companies that are initiating development have received funding from two organizations: the Biomedical Advanced Research and Development Authority (BARDA), which is a division of the Department of Health and Human Services, and the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health. Some companies have received funding from Coalition for Epidemic Preparedness Innovations (CEPI), a global organization based in Oslo. Other companies are funding trials by themselves or through partnerships with other life sciences companies.

About this evaluation

This company did not compile the OpenCorporation questionnaire, for this reason this evaluation was made only on data available to the project staff.

Claims and support from the company

If as a company manager or official of SANOFI you want to enter in touch with our staff, provide more information to OpenCorporation or get an account to access and compile the company questionnaire, please write an email to support@opencorporation.org.

Tell the OpenCorporation team

If you detect corporate behavior in contrast with what emerges from the OpenCorporation corporate rating card in your country, or in the branch where you work, report it to info@opencorporation.org so that our team can take it in account.

More evaluations

This company has other evaluations:

Permament links

The link below will always open the 2020 evaluation:

2020: https://www.opencorporation.org/en/ranking/sanofi/2020    url copied

The link below will always open the latest evaluation available:

Last: https://www.opencorporation.org/en/ranking/sanofi/last    url copied